We assessed the usefulness and limitations of utilizing apparent diŠusion coe‹cient (ADC) values on diŠusion-weighted imaging (DWI) for the diŠerential diagnosis of benign and malignant non-mass-like breast lesions. We retrospectively reviewed 27 such lesions (16 malignant, 11 benign) detected on magnetic resonance (MR) imaging and analyzed the enhancing patterns of dynamic contrast-enhanced DCE-MRI (distribution and internal enhancement), kinetic curve patterns, and ADC values. All images were obtained with a 1.5tesla MR unit, with patients supine. On DCE-MRI, malignant lesions tended to show either segmental or branching-ductal distribution, and when lesions with these patterns were considered malignant, sensitivity was 68.8z; speciˆcity, 63.6z; positive predictive value (PPV), 73.3z; negative predictive value (NPV), 58.3z; and accuracy, 66.7z. Kinetic curve analysis did not reliably diŠerentiate benign and malignant non-mass-like lesions. There was no signiˆcant diŠerence between the mean ADC value of the malignant lesions, 0.968×10 -3 mm 2 /s at b＝1000 s/mm 2 , and that of benign lesions, 1.207×10 -3 mm 2 /s (P ＝0.109). Receiver operating characteristic (ROC) analysis revealed the most eŠective threshold of ADC value for diŠerentiating tumors as 1.1×10 -3 mm 2 /s; values lower than this were observed more often in malignant than benign lesions (P＝0.054). Us of this threshold yielded sensitivity of 68.8z; speciˆcity, 72.7z; PPV, 78.6z; NPV, 61.5z; and accuracy, 70.4z. Combining the ADC value criteria with the analysis of DCE-MRI pattern increased sensitivity to 93.8z, negative predictive value (NPV) to 85.7z, and accuracy to 77.8z but decreased speciˆcity to 54.5z. Use of ADC values does not adequately improve DCE-MRI performance for diŠerential diagnosis of non-mass-like breast lesions, but adding the ADC value criteria to the DCE-MRI pattern analysis improves sensitivity, NPV, and accuracy.
Introduction
Magnetic resonance (MR) imaging is valuable in diagnosing breast lesions. [1] [2] [3] [4] The Breast Imaging Reporting and Data System (BI-RADS) published by the American College of Radiology (ACR) in 2003 introduced theˆrst edition of MR imaging lexicons, 5 with breast lesions detected as either focal mass or non-mass-like enhancement by MR imaging. Evaluating the enhancing patterns of focal mass lesions on dynamic study is useful in diŠerentiating benign and malignant lesions. [6] [7] [8] [9] [10] [11] In contrast, such diŠerentiation is often di‹cult with nonmass-like enhancement because there is no standardized method of interpreting non-mass-like enhancement lesions. [6] [7] [8] 10, [12] [13] [14] Several studies have reported the utility of evaluating apparent diŠusion coe‹cient (ADC) values derived from diŠusion-weighted imaging (DWI) for diŠerentiating benign and malignant lesions. [15] [16] [17] [18] [19] [20] DWI obtains MR signal based on the thermal diŠu-sion of water molecules (Brownian motion), and the rate of water diŠusion is expressed as the ADC value. Malignant tumors tend to show lower ADC values than do normal mammary gland and benign tumors because malignant tumors allow a sig-niˆcantly reduced diŠusion. This is related to increased cellularity, larger nuclei with more abundant macromolecular proteins, and less extracellular space of malignant tumors. [21] [22] [23] However, most studies have evaluated the usefulness of utilizing ADC values in characterizing focal mass lesions 8, 11, [15] [16] [17] [18] ; only two have assessed the ADC values of non-mass-like lesions. 7, 8 We compared the usefulness and limitations of assessing ADC values and evaluating enhanced patterns on dynamic contrast-enhanced MR imaging (DCE-MRI) for diŠerentiating benign and malignant non-mass-like breast lesions.
Materials and Methods

Patients
Between August 2005 and September 2006, 151 women (aged 27 to 81 years; mean, 51.5 years) underwent breast MR imaging for further examination of palpable mass lesions, bloody secretions, or abnormalities on mammography. Of the 151, 63 lesions in 62 women underwent surgical resection or needle biopsy that revealed deˆnite pathology, and 13 additional lesions in 13 women were diagnosed as benign based onˆndings of follow-up studies performed over a 2-year period. No patient underwent any diagnostic procedure, such as aspiration cytology or needle biopsy, before the MR examination.
Two experienced breast radiologists (I. I., with 16 years' experience, and T. I., with six) interpreted the MR images of 76 breast lesions in 75 women and classiˆed the morphological features of the lesions as either mass or non-mass-like lesions based on dynamic study images in theˆrst and third phases. From these, we selected 27 non-mass-like lesions of 27 patients (aged 31 to 81 years, median, 50 years) for this study (Table 1) . Histologicalˆndings obtained in 20 cases revealed 12 invasive ductal carcinomas (IDC), ten of which with predominantly in situ (DCIS), 3 DCIS, one apocrine carcinoma, 3 mastopathies, and one diabetic mastopathy. The remaining 7 cases were considered benign based on follow-up studies over 2 years.
MR imaging
MR imaging was performed using a 1.5-T system (Gyroscan Intera 1.5T; Philips Medical Systems, Best, The Netherlands) with patients in a supine po-sition similar to operation posture. Axial fat-suppressed T 2 -weighted fast spin-echo imaging (FS-T 2 WI) and DWI were performed using a body coil for bilateral breasts. Coronal FS-T 2 WI, DWI, and dynamic MR imaging were performed using 2 Synergy Flex-M Coils (Philips) for aŠected unilateral breasts. DWI was performed with spin-echo echoplanar images (SE-EPI) and sensitivity encoding (SENSE) technique combining chemical shift selective suppression (CHESS). Dynamic MR imaging was performed using 3-dimensional fastˆeld-echo (3D-FFE) images. All sequences were performed under free breathing without use of breast holding techniques.
FS-T 2 WI was performed using parameters: axial: repetition time (TR), 3350 ms; echo time (TE), 80 ms; number of excitations (NEX) 2; slice thickness, 8 mm; inter-slice gap 1 mm; acquisition matrix, 448 ×292;ˆeld of vision (FOV) 42 cm; coronal: TR/ TE, 4000/80 ms; NEX, 2; slice thickness, 2 mm; inter-slice gap, 0 mm; acquisition matrix, 189×192; FOV, 21 cm. DWI was performed with: axial: b＝ 1000 s/mm 2 ; TR/TE, 4508/67 ms; NEX, 1; slice thickness, 8 mm; inter-slice gap, 1 mm; matrix, 89 ×112; FOV, 42 cm; scan time, 59 s; coronal: b＝ 1000 s/mm 2 ; TR/TE, 3621/66 ms; NEX, 4; slice thickness, 4 mm; inter-slice gap, 0 mm; matrix, 64 ×80; FOV, 421 cm; scan time, 65 s. A dynamic study was performed using 3D-FFE: TR/TE, 8.6/ 4.2 ms; ‰ip angle, 209 ; NEX, 2; slice thickness, 2 mm with 1 mm intersectional overlap; matrix, 208 ×208; FOV, 21 cm; scan time, 2 min 12 s. Acquisition of post-contrast series was begun after acquisition of a pre-contrast series: 0.1 mmol/kg body weight of gadopentetate dimeglumine was manually injected intravenously, followed immediately by injection of 20 mL of saline solution. Three phases of post-contrast series were obtained with intervals of 2 min 12 s.
Image interpretation
Two breast radiologists (I. I. and T. I.) blinded to clinical information and histopathological diagnosis independently interpreted the MR images of all the cases and determinedˆnal results by consensus.
We evaluated the enhanced patterns in theˆrst and third phases of DCE-MRI based on the type of distribution and internal enhancement and according to BI-RADS-MRI criteria as well as results of previous studies. 5, 7, [11] [12] [13] Distribution was characterized as focal, linear, ductal, segmental, regional, multiple regions, and diŠuse; internal enhancement was characterized as homogeneous, heterogeneous, stippled, clumped, reticular, or clustered ring en- We assessed kinetic curves in a circular region of interest (ROI) that minimally covered the areas showing highest signal intensity on DCE-MRI and then categorized their patterns based on BI-RADS-MRI criteria. 5 We classiˆed the initial rise into slow, medium, and rapid patterns and the delayed phase into persistent, plateau, and washout pat- terns. An increase in signal intensity greater than 10 z relative to the peak enhancement in theˆrst 3 min was deˆned as a persistent pattern; a decrease in signal intensity greater than 10z was deˆned as a washout pattern; and no increase or decrease above those values was deˆned as plateau pattern. 9 We evaluated axial and coronal DWI whether or not we observed an area of high intensity. To calculate ADC values, an experienced breast radiological technologist (T. Y.)ˆxed an ROI that minimally covered the areas showing the highest signal intensity on axial DWI and coronal DCE-MRI, which was then conˆrmed by 2 breast radiologists (I. I. and T. I.). When no high signal intensity was observed on DWI, the ROI was set in the enhanced lesion on DCE-MRI. In the case of diŠuse enhancement, an ROI was set to cover the area of highest signal intensity on DWI. ADC values were calculated using the algorithm represented by the following equation, where IS (b 0 ) and Is (b 1 ) are signal intensities in the ROI obtained by 2 gradient factors, b 0 and b 1 :
We performed receiver operating characteristic (ROC) curve analysis to deˆne the most eŠective threshold ADC value for distinguishing benign and malignant lesions. We determined the best cut-oŠ value using Youden statistics, Y＝sensitivity-(1-speciˆcity), which allows a balance between good results of sensitivity and speciˆcity. We used the threshold ADC values based on ROC curve analysis to evaluate the ability of utilizing ADC values to diŠerentiate benign and malignant lesions. We calculated the sensitivity, speciˆcity, positive predictive value (PPV), negative predictive value (NPV), and accuracy using combinations of DCE-MRI patterns and criteria regarding ADC values.
We analyzed false-positive and false-negative cases to clarify the limitations of using ADC values for making diŠerential diagnosis.
We compared the ADC values of the 2 groups using a nonparametric 2-tailed Mann-Whitney U test and analyzed categorical data using Fisher's exact test. Pº0.05 was considered statistically signiˆcant.
Results
Tables 1 and 2 summarize DCE-MRIˆndings, kinetic curve patterns, and ADC values of the 27 non-mass-like lesions.
Malignant lesions tended to show either segmental (P＝0.054) or branching-ductal distribution on DCE-MRI without signiˆcant diŠerence (P＝0.090). When lesions showing those patterns were considered malignant, sensitivity was 68.8z (11/16); speciˆcity, 63.6z (7/11); PPV, 73.3z (11/15); NPV, 58.3z (7/12); and accuracy, 66.7z (18/27). There were 4 false-positive cases (Cases 1, 2, 3, 5) that comprised 3 cases of mastopathy or diabetic mastopathy showing segmental distribution ( Fig.  1 ) and one benign case (follow-up study) showing branching-ductal distribution. Five false-negative cases (Cases 17, 18, 25, 26, 27) cases consisted of 4 cases of IDC (including three with predominantly DCIS) and one DCIS. All cases showed either diŠuse or stippled distribution.
Absence of statistical diŠerence among curve patterns on kinetic curve analysis proved this method unreliable for diŠerentiating benign and malignant non-mass-like lesions (Fig. 2) .
There was no statistical diŠerence between the median ADC value of the malignant lesions, 0.968 ×10 -3 mm 2 /s, and that of benign lesions, 1.207× 10 -3 mm 2 /s (P＝0.109). ROC curve analysis revealed the most eŠective threshold ADC value as 1.1 ×10 -3 mm 2 /s ( Fig. 3 ). Malignant lesions showed ADC values lower than 1.1×10 -3 mm 2 /s more often than benign lesions (P＝0.054), and using this threshold, sensitivity was 68.8z (11/16); speciˆcity, 72.7z (8/11); PPV, 78.6z (11/14); NPV, 61.5z (8/13); and accuracy, 70.4z (19/27). There were 3 false-positive and 5 false-negative cases. Possible reasons for intralesional hemorrhage or complicated cysts were decreased ADC value based on the pattern of signal intensity of the lesion (Cases 3, 5) and/or pathologicalˆndings (Case 3, Fig. 4 ) in 2 false-positive cases. An intramammary lymph node was supposed to be the cause of the low ADC value in the remaining falsepositive case. The 5 false-negative results were thought to be related to lack of identiˆcation on DWI (Case 23, IDC with predominantly DCIS); duct dilatation by intraductal tumor (Case 21, IDC with predominantly DCIS); or a volume averaging eŠect due to contamination of the background tissue (Cases 13, 22, IDC with predominantly DCIS; Case 18, IDC). Sensitivity for diagnosis was 93.8z (15/16); speciˆcity, 54.5z (6/11); PPV, 75.0z (15/20); NPV, 85.7z (6/7); and accuracy, 77.8z (21/27) when the lesions with DCE-MRI patterns suggested malignancy (segmental or branching- 
Discussion
On MR imaging, theˆrst step for diŠerential diagnosis of breast lesions should be to assess the conˆguration, mass, or non-mass-like enhancement. 5 Previous studies investigated the high sensitivity of breast MR imaging but reported low and variable speciˆcities. 1, 2, 4, 9, 10, 13, 14, 17, 18 In addition, no standardized method for interpreting the evaluation of non-mass-like enhancement has been established. [6] [7] [8] 10, [12] [13] [14] Because many cases of DCIS or invasive ductal carcinoma with a predominantly intraductal component tend to show non-mass-like enhancement on MR imaging, diagnosis can be di‹cult. Previous studies investigated the diagnostic values of enhancing patterns on DCE-MRI or of kinetic curve analysis, but the diagnostic values of these methods are controversial. [6] [7] [8] [9] [10] Assessing ADC values on DWI could be promising for evaluating mass lesions because of the high sensitivity of DWI [15] [16] [17] ; a low ADC value represents breast cancer as well as dense mucous tissue, such as pus, or hemorrhage. [15] [16] [17] [18] [19] [20] [21] [22] [23] However, only 2 studies have evaluated the ADC values of non-mass-like lesions. 7, 8 The current study analyzed the capacity of both enhancing patterns and the ADC values of non-mass-like lesions to reveal the usefulness and limitations of breast MR imaging for the diŠerential diagnosis of non-mass-like breast lesions.
Ourˆndings of segmental distribution on DCE-MRI in 27.3z (3/11) of benign lesions and 68.8z (11/16) of malignant lesions are consistent with results reported by other investigators; Yabuuchi's group 7 reported segmental distribution in 28.6z of benign and 77.4z of malignant cases, and Tozaki's team, 12 in 0z of benign and 56z of malignant lesions. Yuen and colleagues 24 reported segmental distribution in 18.5z of benign cases, 11.5z of high risk lesions, and 70z of malignant lesions. Liberman and associates 10 reported the highest frequency of carcinoma among the non-mass lesions with segmental enhancement (67z). On the other hand, Sakamoto and colleagues 14 reported no sig-niˆcant diŠerence between segmental distribution in benign (17z) and malignant lesions (30z), but signiˆcant diŠerence in branching-ductal pattern between benign (10z) and malignant lesions (50 z).
Clumped internal enhancement is commonly observed in DCIS, 12 but there were only 3 cases of DCIS in this study, and we observed no such enhancement in any malignant lesion. CRE, a clustering of minute ring enhancements, has also been reported to suggest malignancy: 44z vs. 0z 12 ; 63 z vs. 4z 13 ; 100z vs. 3z 14 ; and 74z vs. 0z 24 in malignant vs. benign lesions. CRE is believed to be the enhancement of ductal carcinoma and periductal stroma in DCIS, 12 but in the current series, we observed CRE in DCIS (1/3, 33.3z) and in IDC with some DCIS component (4/13, 30.8z ). This result is consistent with results reported by Yuen and associates, 57z of IDC with DCIS less than 25 z showed CRE. 24 (Yuen and associates reported 57 z of IDC showed CRE. These IDC cases were with less DCIS: less than 25z.) Kinetic curve analysis was not reliable for differentiating benign and malignant non-mass-like lesions in the current study, a result consistent with others'ˆndings. 6, 7, 25 Although kinetic curve patterns represent the vascularity and stroma of lesions, benign non-mass-like lesions, such as mastopathy, can show either increased vascularity or stromal edema depending on the menstrual cycle or activity, which may thus lead to a false-positive result. 26 Another factor associated with false-negative results is a volume averaging eŠect due to contamination of the background tissue.
Using ADC values can be an option for diagnosing breast lesions, but only 2 reports have evaluated their utility in characterizing non-mass lesions. 7, 8 Yabuuchi and associates demonstrated an ADC value less than 1.3×10 -3 mm 2 /s as the strongest indicator of malignancy in non-mass-like breast lesions, 7 and Partridge and associates achieved high sensitivity and improved PPV by applying an ADC threshold of 1.81×10 -3 mm 2 /s to DCE-MRI in both mass and non-mass-like breast lesions. 8 In this series, we found the most feasible ADC value to depict malignant non-mass-like lesions to be less than 1.1×10 -3 mm 2 /s. The diŠerence can be explained by diŠerence in the study population. Moreover, many technical variables can aŠect the ADC values, such as diŠerent MR units, pulse sequences, or b-factors, and this is a signiˆcant limitation of applying ADC values in the clinical setting. Further studies are required to establish a standard ADC value to be used as a threshold in the clinical setting.
The current study analyzed false-positive and false-negative cases based on DCE-MRI and ADC criteria. Three of 4 false-positive cases showed segmental distribution with the DCE-MRI criteria. About 30z of benign lesions may show segmental distribution. 7,24 DCE-MRI was performed for the unilateral breast in the current series. DCE-MRI of bilateral breasts, which enables comparison of the contralateral breast, could have been useful to avoid this overdiagnosis, because segmental distribution is expected to be symmetric in benign lesions. Two false-positive cases (Cases 2, 3, mastopathy) also showed CRE (Fig. 2) . Two studies showed CRE in benign lesions in a small number of cases (one of 26 cases and one of 83 cases). 13, 14 The reason for this false-positive result has not been fully analyzed, but the pathological features corresponding to CRE, periductal stroma surrounding dilated ducts or cystic lesions, 12,13 may be seen in mastopathy.
The major reason for false-positive results with the ADC value criteria was thought to be associated with intralesional hemorrhage or highly dense ‰uid. Complicated cyst or hemorrhagic areas can be avoided by referring to T 1 -weighted images showing high signal intensity. However, it may be di‹cult to set the appropriate ROI for calculating ADC values in cases of complicated cysts or hemorrhagic lesions with small, multiple, or scattered areas of high signal intensity. An intramammary lymph node associated with mastopathy was supposed to be the cause of the low ADC value in one false-positive case (Case 10). No published study has assessed the intramammary lymph nodes on Magnetic Resonance in Medical Sciences DWI; however, regional lymph nodes, such as in the axilla, neck, and pelvis, can show high signal intensity and low ADC values on DWI, even if they are benign. [27] [28] [29] [30] Volume-averaging eŠects, that is, contamination of the background breast tissue in the ROI, may explain false-negative results obtained using the ADC value criteria. It is di‹cult to set an appropriate ROI in small lesions or lesions with sparse cancer cells and avoid such contamination. Slice thickness is one factor that in‰uences the spatial resolution and volume averaging eŠect of an image. In the current series, we used slice thicknesses of 8 mm for axial images and 4 mm for coronal images. Thinner slices may have decreased the false-negative results, but further studies are necessary to determine the appropriate scan protocol for this purpose.
We found the performance of DWI and DCE-MRI for diŠerentiating benign and malignant breast lesions almost equivalent, 31, 32 but combining DCE-MRIˆndings and ADC values yielded high sensitivity, NPV, and accuracy. The combination criteria identiˆed 4 additional true-positive cases (Cases 17, 25, 26, 27) with only one additional false-negative case (Case 18), showing complementary abilities for diagnosis. However, adding the DWI criteria to DCE-MRI did not signiˆcantly increase the PPV. Partridge's group reported that adding DWI criteria might improve PPV in smaller lesions (Ã1 cm) compared to larger enhanced lesions. 8 The relatively large size of lesions in our study may explain the absence of improved PPV when we combined the assessment of ADC value and DCE-MRIˆndings.
Reduced speciˆcity is the drawback of adding DCE-MRI criteria and ADC value. By adding DCE-MRI to ADC value, we had 2 false-positive cases, and by adding ADC value to DCE-MRI, we had one false-positive case. Thus, use of ADC value does resolve the low speciˆcity in diŠerentiating benign and malignant lesions, which is the major deˆciency of MR imaging of the breast. 1, 2, 4, 9, 10, 13, 14, 17, 18 Other sequences, e.g., FS-T 2 WI and T 1 WI, may be useful in decreasing false-positive results in some cases, such as Cases 1 (diabetic mastopathy) and 10 (intramammary lymph node). However, further studies are necessary to solve this problem.
Our study has several limitations. First, to localize lesions precisely for planning breast-conservation surgery, we positioned the patients in supine position, which may not be a standard technique for breast MR imaging. Tozaki and associates 33 reported the feasibility of supine MR mammography, and we found little respiratory motion ar-tifact in spite of uncontrolled breathing, which can exaggerate such artifact in the supine position. Second, we had no pathological conˆrmation in seven of 11 benign cases. These cases showed no evidence of malignancy on physical examination, mammography, or sonography and were followed for 2 years, which su‹ciently guaranteed the benign nature of the lesions. Third, our study was limited because it is retrospective and includes only a small number of patients. Based on our results, we will conduct a further prospective study.
In conclusion, the use of ADC values is equivalent to that of DCE-MRI for diagnosing benign and malignant non-mass-like breast lesions. Combining ADC value criteria with DCE-MRI pattern analysis increased sensitivity, NPV, and accuracy but decreased speciˆcity. Therefore, further study is needed to improve the speciˆcity of these diagnostic criteria.
